| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.2M | +36.7% |
| Cost of Revenue | $4.3M | +40.3% |
| Gross Profit | $1.9M | +29.0% |
| R&D Expense | $75K | -34.5% |
| SG&A Expense | $3.7M | +36.7% |
| Operating Income | -$1.9M | -39.0% |
| Interest Expense | $22K | +16.0% |
| Pre-tax Income | -$1.6M | -17.5% |
| Net Income | -$1.6M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $643K | +86.3% |
| Accounts Receivable | $123K | +51.7% |
| Inventory | $1.9M | +119.4% |
| Current Assets | $3.0M | +101.9% |
| Total Assets | $4.7M | +125.5% |
| Current Liabilities | $1.4M | +35.7% |
| Total Liabilities | $2.0M | +37.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$769K | -38.4% |
| Capital Expenditures | $24K | +330.5% |
| Investing Cash Flow | $518K | +9512.7% |
| Financing Cash Flow | $550K | -34.3% |
| Free Cash Flow | -$793K | -41.2% |
| -17.5% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Stockholders' Equity |
| $2.6M |
| +350.1% |